Enliven Therapeutics (stock code: ELVN) recently released its financial report for the fourth quarter and full year of fiscal 2025, while also updating the market on the company's latest business developments.

A16z upgrades Jolt zkVM to introduce zero-knowledge support

Applied Digital raises over $2.1 billion for Oracle-related projects

Hyster-Yale Materials Handling expects to achieve profitability in the first half of 2026, reversing previous minor losses, as strong revenue growth is anticipated with improved business volume in the second half of this year.

Hyster-Yale Materials Handling C announced that the company has launched a restructuring plan aimed at achieving annual cost savings of $40 million to $45 million starting from the first quarter of 2026.